Sign inJoin waitlistJoin the waitlist

HS

Hina Shah

Physician · Dana-Farber Cancer Institute

Credentials: ·

History

Dana-Farber Cancer Institute · Brigham and Women's Hospital
2022–Present

Nuclear Medicine
2006–2009
Medical School
2002–2006

Research

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial
JAMA Oncology · 2020 · 307 citations
PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up
Review · Seminars in Nuclear Medicine · 2018 · 22 citations
Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful
Review · Korean Journal of Radiology · 2017 · First of 6 authors · 20 citations

Heather Jacene
12 papers
Praful Ravi
4 papers
AK
Abhishek Keraliya
3 papers · 3 as a fellow
Kerry Kilbridge
3 papers
MR
Matthew Robertson
3 papers
RC
Rami Chatta
3 papers
SP
Saurabh Pallod
3 papers
Xiaolin Wei
3 papers · 2 as a resident
Alicia Morgans
2 papers
Anand Vaidya
2 papers
Andrew Schneider
2 papers · 2 as a resident
Atish Choudhury
2 papers